Unknown

Dataset Information

Reversing the effects of androgen-deprivation therapy in men with metastatic castration-resistant prostate cancer.


ABSTRACT:

Objective

To investigate whether bipolar androgen therapy (BAT), involving rapid cyclic administration of high-dose testosterone, as a novel treatment for metastatic castration-resistant prostate cancer (mCRPC) promotes improvements in body composition and associated improvements in lipid profiles and quality of life.

Patients and methods

Men from two completed trials with computed tomography imaging at baseline and after three cycles of BAT were included. Cross-sectional areas of psoas muscle, visceral and subcutaneous fat were measured at the L3 vertebral level. Functional Assessment of Chronic Illness Therapy - Fatigue questionnaire and 36-item short-form health survey were used to assess quality of life.

Results

The 60 included patients lost a mean (sd) of 7.8 (8.

SUBMITTER: Marshall CH 

PROVIDER: S-EPMC9844547 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature